Turn this role into an interview — a resume and cover letter built around what this employer wants.
MoonLake Immunotherapeutics is seeking a Payer Account Lead to drive engagement with U.S. GPOs, PBMs, payers, and IDNs to ensure timely access for sonelokimab. You will lead payer strategy development pre- and post-approval and serve as the external-facing contact for priority payer accounts.
Responsibilities include leading formulary reviews, tracking payer policy developments, and coordinating with Pricing/Contracting for rebates. Strong experience in U.S.
The Payer Account Lead will be responsible for leading the engagement with U.S. GPOs, PBMs, payers, and IDNs to ensure timely and sustainable access for sonelokimab. This role will help drive pre- and post-approval payer strategies, support value proposition development, and serve as the primary external-facing contact with priority payer accounts.
The Payer Account Lead will be responsible for leading the engagement with U.S. GPOs, PBMs, payers, and IDNs to ensure timely and sustainable access for sonelokimab. This role will help drive pre- and post-approval payer strategies, support value proposition development, and serve as the primary external-facing contact with priority payer accounts.
MoonLake is a dynamic and innovative company pushing the boundaries of possibility, and we are looking for passionate individuals to join our stellar team.
An opportunity to learn and grow alongside experienced professionals in a supportive and innovative biotech environment.
Contribute to ground-breaking projects that have the potential to transform global healthcare.
Enjoy a healthy work-life balance while making meaningful contributions to our team.
A clear path for career progression, with the chance to take on more responsibilities as you develop your skills.
MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company unlocking the potential of sonelokimab, a novel investigational Nanobody® for the treatment of the inflammatory disease, to revolutionize outcomes for patients.
We continue to make significant progress in our Global Clinical Development Programs. The company’s focus is on inflammatory diseases with a major unmet need, including hidradenitis suppurativa and psoriatic arthritis – conditions affecting millions of people worldwide with a large need for improved treatment options. MoonLake was founded in 2021 and is headquarted in Zug, with hubs in Cambridge & Porto.
Further information is available at www.moonlaketx.com